Gaurav Munj 2022-03-04T06:42:16+00:00 Press Releases Site - Investor Relations Nav Overview Press Releases Events and Presentations Financial Filings Stock Information Corporate Governance Contact Upcoming and Recent Events Corporate Presentation SEC Filings Stock Quote & Chart Historical Lookup Governance Documents Committees Year None2025202420232022 January 13, 2025 Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy January 12, 2025 Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs January 7, 2025 Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference BIOHAVEN (BHVN) Volume Market Cap 52 Week High 52 Week Low Minimum 15 minutes delayed. Source: LSEG
Year None2025202420232022 January 13, 2025 Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy January 12, 2025 Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs January 7, 2025 Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025 Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
January 12, 2025 Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
